News | Thrombectomy Devices | April 20, 2016

Boston Scientific Corporation Recalls Fetch 2 Aspiration Catheter

FDA Class 1 recall initiated over concerns about shaft breakage, which may cause serious injury or death

Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall

April 20, 2016 — Boston Scientific Corp. announced a U.S. Food and Drug Administration (FDA) Class 1 recall of the Fetch 2 Aspiration Catheter because the catheter shaft may break at various points along the device, before or during procedures. If breakage occurs while the device is in a patient, pieces of the catheter may block blood supply to the heart or blood vessels. This could result in the need for additional medical procedures, patient injury, or death.

The company initiated the recall on March 22, affecting 17,455 devices nationwide (including Washington, D.C. and the Virgin Islands). The affected devices were manufactured between June 11, 2014 and Feb. 19, 2016, and distributed between June 24, 2014 and March 11, 2016.

The Fetch 2 Aspiration Catheter is intended to remove small blood clots from peripheral veins and coronary arteries to restore blood flow to the heart.

Customers are advised to discontinue use of all affected products immediately and return unused products to Boston Scientific.

For more information: www.bostonscientific.com, www.fda.gov


Related Content

News | Thrombectomy Devices

March 19, 2026 — Endovascular Engineering, Inc. has announced that two abstracts related to the ENGULF study and the ...

Home March 20, 2026
Home
News | Thrombectomy Devices

Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...

Home January 19, 2026
Home
News | Thrombectomy Devices

Dec. 10, 2025 — Medtronic plc has announced the first commercial use of the Liberant thrombectomy system (Liberant) ...

Home January 07, 2026
Home
News | Thrombectomy Devices

Dec. 16, 2025 — A new study, published in the American Journal of Cardiology, found that the use of Computer Assisted ...

Home December 23, 2025
Home
News | Thrombectomy Devices

Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...

Home November 07, 2025
Home
News | Thrombectomy Devices

Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...

Home October 27, 2025
Home
News | Thrombectomy Devices

Sept. 2, 2025 — Imperative Care, Inc. has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its ...

Home September 02, 2025
Home
News | Thrombectomy Devices

June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This ...

Home June 16, 2025
Home
News | Thrombectomy Devices

March 24, 2025 — Imperative Care, Inc. recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Home March 24, 2025
Home
News | Thrombectomy Devices

Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous ...

Home January 30, 2025
Home
Subscribe Now